Skip to main content
. 2021 Sep 10;13(9):1448. doi: 10.3390/pharmaceutics13091448

Figure 3.

Figure 3

Cyclic strain bioreactor and of the 3D scaffold and representation of the two different experiments set up. Image of the cyclic strain bioreactor and software interface (a). 3D scaffold placed in the bioreactor culture chamber (b). Schematic representation of the two series of experiments performed: hGDF-5 was supplemented in the culture medium (c) or encapsulated within PLGA nanocarriers for its local controlled delivery (d).